Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Lifecare AS ( (DE:LFC0) ) has issued an announcement.
Lifecare ASA has completed the subscription period for its partially underwritten rights issue, which is expected to result in the issuance of 160 million new shares at NOK 0.50 per share, raising gross proceeds of NOK 80 million. Preliminary figures show subscriptions for approximately 142.8 million offer shares and around 214 million associated warrants, with subscribers receiving warrants in two series at no additional cost, underscoring solid shareholder participation and providing the company with fresh capital to support its development activities.
More about Lifecare AS
Lifecare ASA is a medical sensor company focused on developing technology for sensing and monitoring various body analytes, with a primary emphasis on bringing next-generation continuous glucose monitoring systems to market. Using osmotic pressure as its sensing principle, the company’s sensor technology is intended for detecting and tracking a wide range of molecules in humans and pets.
Average Trading Volume: 568,098
Current Market Cap: NOK159.4M
See more data about LFC0 stock on TipRanks’ Stock Analysis page.